Rating History for Y-mAbs Therapeutics (YMAB) by Canaccord

More Stocks Rated by Canaccord | Latest Ratings for YMAB
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/6/2025 William Maughan Downgrade Hold
(Buy)		 N/A
(N/A)		 4.19
(8.61)		 105.49% Details